Skip to main content
Clinical Trials/NCT02594683
NCT02594683CompletedNot Applicable

A Follow-up Study of a Randomised, Controlled, Study to Investigate the Effects of a New Infant Formula Given in the First 12 Months of Life on Growth and Body Composition up to 5 Years of Age

Danone Asia Pacific Holdings Pte, Ltd.2 sites in 1 country359 target enrollmentStarted: August 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
359
Locations
2
Primary Endpoint
Body Mass Index (BMI)

Study Overview

Brief Summary

A follow-up study of a randomised, controlled, study to investigate the effects of a new infant formula given in the first 12 months of life on growth and body composition up to 5 years of age

Detailed Description

A follow-up study of a randomised, controlled, study to investigate the effects of a new infant formula given in the first 12 months of life on growth and body composition up to 5 years of age. Participants from Venus study will be invited to participate in this follow-up study.

Hypothesis

Significant difference in body mass index (BMI) development for subjects who had received infant formula and follow on formula with scGOS/lcFOS/Nuturis® compared to the control product scGOS/lcFOS and standard formula. No significant difference in growth of subjects who had received infant formula and follow on formula with scGOS/lcFOS/Nuturis® compared to the breast-feeding reference group.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
3 Years to 5 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Participation in the intervention period of VENUS study until 12 months of age or participation in the VENUS study as breast-fed reference group
  • Written informed consent from parent(s) or legally acceptable representatives

Exclusion Criteria

  • Investigator's uncertainty about the willingness or ability of the child and parents to comply with the protocol requirements

Outcomes

Primary Outcomes

Body Mass Index (BMI)

Time Frame: up to 5 years of age

Secondary Outcomes

  • Sum of skin fold thicknesses (triceps, biceps, suprailiac, subscapular)(up to 5 years of age)
  • Z-scores of Weight-for-age(up to 5 years of age)
  • Z-scores of Weight-for-height(up to 5 years of age)
  • Z-scores of BMI-for-age(up to 5 years of age)
  • Z-scores of Height-for-age(up to 5 years of age)
  • Z-score of Head circumference-for-age(up to 5 years of age)
  • Z-score of Skinfold-for-age (subscapular, triceps)(up to 5 years of age)
  • Z-score of Mid-upper-arm-circumference-for-age(up to 5 years of age)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials